Bibliography for Genetics and Psychiatry

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically. Articles from the bibliography that are reprinted in this issue are in bold type.

Craddock N, O’Donovan MC, Owen MJ: Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32:9–16

De Leon J, Armstrong SC, Cozza, KL: Med-Psych drug-drug interactions update: clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 2006; 47:75–85

Gogos JA, Gerber DJ: Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci. 2006; 27:226–233

Kendler KS, Gatz M, Gardner CO, Pedersen NL: A Swedish national twin study of lifetime major depression. Am J Psychiatry 2006; 163:109–114

Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR: Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci U S A 2006; 103:6747–6752

McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papamocolaou J, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006; 78:804–814

Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri AR, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR: Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A 2006; 103:6269–6274

Rutter M, Kim-Cohen J, Maughan B: Continuities and discontinuities in psychopathology between childhood and adult life. J Child Psychol Psychiatry 2006; 47:276–295

Toga AW, Thompson PM, Sowell ER: Mapping brain maturation. Trends Neurosci 2006; 29:148–159

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (STAR*D Study Team): Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163:28–40

Abelson JF, Kwan KY, O’Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Raŝin M-R., Gunel M, Davis NR, Ercan-Sencicek G, Guez DH, Spertus JA, Lackman JF, Dure LS IV, Kurlan R, Singer HS, Gilberg DL, Farhi A. Louvi A. Lifton RP, Ŝestam N, State MW: Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 2005; 310:317–320; comment, 2005; 310:211

Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O’Donovan MC: Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005; 14:1947–1954

Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR: Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A. 2005; 102:8627–8632

Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M., Gasperoni T, Tuulio-Henriksson A. Pirkola T, Toga AW, Kaprio J, Mazziotta J, Peltonen L: Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry. 2005; 62:1205–1213

Fanous AH, Kendler KS: Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005; 10:6–13

Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005; 6:521–532

Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10:40–68

Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, Mann K, Buchel C: Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8:20–21

Kendler KS: “A gene for”: the nature of gene action in psychiatric disorders. Am J Psychiatry 2005; 162: 1243–1252

Kendler KS: Psychiatric genetics: a methodologic critique. Am J Psychiatry 2005; 162:3–11

Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B: The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62:529–535

Knoppers BM, Chadwick R: Human genetic research: emerging trends in ethics. Nat Rev Genet 2005; 6: 75–79

Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, Thomson PA, Hill EV, Brandon NJ, Rain JC, Camargo LM, Whiting PJ, Houslay MD, Blackwood OH, Muir WJ, Porteous DJ: DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005; 18:310:1187–1191; comment 310:1128–1129

Owen MJ, Craddock N, O’Donovan MC: Schizophrenia: genes at last? Trends Genet 2005; 21:518–525

Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR: 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8:828–834

Sharma RP: Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophr Res 2005; 72:79–90

Dinwiddie SH, Hoop J, Gershon ES: Ethical issues in the use of genetic information. Int Rev Psychiatry 2004; 16:320–328

Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR: Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004; 101:12604–12609

Gordon JA, Hen R: Genetic approaches to the study of anxiety. Annu Rev Neurosci 2004; 27:193–222

Kelsoe JR: Genomics and the Human Genome Project: implications for psychiatry. Int Rev Psychiatry 2004; 16: 294–300

Kendler KS: Major depression and generalised anxiety disorder: same genes, (partly) different environments–revisited. Reprinted in Focus 2004; 2:416–425

Shih RA, Belmonte PL, Zandi PP: A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004; 16:260–283

Weinshilboum R, Wang L: Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 2004; 3:739–748

Biesecker BB, Peay HL. Ethical issues in psychiatric genetics research: points to consider. Psychopharmacology (Berl) 2003; 171:27–35

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386–389 (Reprinted in FOCUS, Winter 2005)

Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR: Catechol O-methyltransferase val¹⁵⁸-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003; 100: 6186–6191

Merikangas KR, Risch N: Genomic priorities and public health. Science 2003; 302:599–601

Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R: Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851–854

Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR: Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297:400–403

Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val^108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98:6917–6922

Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158:1568–1578

Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL: Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 2001; 98:11650–11655

Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW: Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 2000; 343:450–456

Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994; 265:2037–2048